Miragen Therapeutics Inc of Boulder, CO, a company, filed a Form D amendment with the SEC on 2009-05-27. The offering totals $12.0M, of which $12.0M was reported sold. Industry: Biotechnology.
Showing 25 of 29 people.
| Name | Role | Location |
|---|---|---|
| Bruce Booth | Director | Cambridge, MA |
| Marvin Caruthers | Director | Boulder, CO |
| Kyle Lefkoff | Director | Boulder, CO |
| Bruce Booth | Executive Officer | Cambridge, MA |
| Kyle A Lefkoff | Director | Boulder, CO |
| Kevin E Koch | Director | Boulder, CO |
| Paul D Rubin | Executive Officer | Boulder, CO |
| Jason A Leverone | Executive Officer | Boulder, CO |
| Adam S Levy | Executive Officer | Boulder, CO |
| Thomas E Hughes | Director | Boulder, CO |
| Kyle H Lefkoff | Director | Boulder, CO |
| Marvin H Caruthers | Director | Boulder, CO |
| David J Rodman | Executive Officer | Boulder, CO |
| Joshua E Resnick | Director | Boulder, CO |
| John E Creecy | Director | Boulder, CO |
| Bruce L Booth | Director | Boulder, CO |
| Bruce L Booth | Executive Officer | Boulder, CO |
| Christopher J Morl | Executive Officer | Boulder, CO |
| Thomas S Hughes | Director | Boulder, CO |
| Marvin S Caruthers | Director | Boulder, CO |
| Kyle S Lefkoff | Director | Boulder, CO |
| Bruce S Booth | Director | Boulder, CO |
| Bruce S Booth | Executive Officer | Boulder, CO |
| John S Creecy | Director | Boulder, CO |
| Jason S Leverone | Executive Officer | Boulder, CO |
| Filed | Form | Offering | Sold |
|---|---|---|---|
| 2017-02-14 | D | $40.7M | $40.7M |
| 2015-11-12 | D | $41.1M | $25.0M |
| 2015-02-17 | D | $20.0M | $8.5M |
| 2014-06-26 | D/A | $20.0M | $13.0M |
| 2012-04-24 | D | $20.0M | $6.0M |
| 2012-01-03 | D/A | $6.0M | $6.0M |
| 2010-09-21 | D | $6.0M | $3.0M |
| 2009-05-27 | D | $53K | $53K |